• Latest Posts

Schizophrenia and Drug Delivery Biotechs Sign a Major Pharma Partner

German Pharma and Biotech Gang Up on NASH in an Exciting Collaboration

German Humira Biosimilar for Inflammatory Diseases Cleared for EMA Approval

French Biotech Lures Big Pharma with Fibrosis Treatments

Boehringer Ingelheim Enters the Clinic with Two New Diabetes Drugs

Another Pharma sloughs off Small Molecules to focus on Biologics


Boehringer’s Biosimilar could take a Chunk out of the Cancer Market

Boehringer enters the Biosimilar War against Blockbuster Humira

Overseas Deaths in the Clinic come as a Blow to Boehringer Ingelheim

New Psoriasis Antibody Therapy puts pressure on Best-Seller drug Humira

Boehringer buys a €210M ticket to Virus-based Immuno-Oncology

Biotech-funded ‘Angels Initiative’ wants to create 1500 Stroke centres across Europe